Itron, Inc. (NASDAQ:ITRI – Free Report) – Equities researchers at Zacks Research reduced their FY2027 EPS estimates for shares of Itron in a research note issued on Thursday, January 29th. Zacks Research analyst Team now forecasts that the scientific and technical instruments company will earn $6.95 per share for the year, down from their prior forecast of $6.96. Zacks Research has a “Strong Sell” rating on the stock. The consensus estimate for Itron’s current full-year earnings is $5.33 per share. Zacks Research also issued estimates for Itron’s Q4 2027 earnings at $1.73 EPS.
A number of other equities analysts have also issued reports on the company. Stephens raised Itron from an “equal weight” rating to an “overweight” rating and set a $130.00 price target for the company in a research note on Monday, November 3rd. JPMorgan Chase & Co. raised their target price on Itron from $145.00 to $155.00 and gave the company an “overweight” rating in a research note on Thursday, October 16th. Johnson Rice upgraded shares of Itron from an “accumulate” rating to a “buy” rating and set a $130.00 price target on the stock in a research report on Monday, January 5th. Argus reissued a “hold” rating on shares of Itron in a report on Tuesday, November 4th. Finally, Robert W. Baird reaffirmed a “neutral” rating and issued a $118.00 price objective (down previously from $137.00) on shares of Itron in a research note on Friday, October 31st. Eight investment analysts have rated the stock with a Buy rating, four have given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $136.10.
Itron Price Performance
NASDAQ ITRI opened at $100.45 on Monday. Itron has a 12 month low of $90.11 and a 12 month high of $142.00. The firm has a market capitalization of $4.60 billion, a PE ratio of 18.07, a P/E/G ratio of 0.56 and a beta of 1.48. The company’s 50 day simple moving average is $97.37 and its 200 day simple moving average is $113.18. The company has a debt-to-equity ratio of 0.46, a current ratio of 2.17 and a quick ratio of 1.91.
Insider Activity
In other Itron news, SVP John F. Marcolini sold 553 shares of the company’s stock in a transaction dated Monday, November 24th. The shares were sold at an average price of $96.51, for a total transaction of $53,370.03. Following the completion of the sale, the senior vice president directly owned 13,843 shares of the company’s stock, valued at approximately $1,335,987.93. This represents a 3.84% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, SVP Christopher E. Ware sold 343 shares of the firm’s stock in a transaction dated Monday, November 24th. The stock was sold at an average price of $96.51, for a total transaction of $33,102.93. Following the completion of the transaction, the senior vice president owned 18,774 shares of the company’s stock, valued at approximately $1,811,878.74. The trade was a 1.79% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last quarter, insiders have sold 2,971 shares of company stock worth $286,731. 1.51% of the stock is owned by company insiders.
Institutional Trading of Itron
Large investors have recently added to or reduced their stakes in the company. Private Trust Co. NA boosted its position in shares of Itron by 112.4% in the fourth quarter. Private Trust Co. NA now owns 274 shares of the scientific and technical instruments company’s stock worth $25,000 after buying an additional 145 shares during the period. Twin Peaks Wealth Advisors LLC purchased a new stake in Itron in the 2nd quarter worth about $30,000. Employees Retirement System of Texas acquired a new stake in Itron during the 3rd quarter worth about $32,000. Bessemer Group Inc. grew its stake in Itron by 125.7% during the 2nd quarter. Bessemer Group Inc. now owns 255 shares of the scientific and technical instruments company’s stock valued at $34,000 after acquiring an additional 142 shares in the last quarter. Finally, Optiver Holding B.V. acquired a new position in shares of Itron in the 3rd quarter valued at about $36,000. 96.19% of the stock is owned by institutional investors and hedge funds.
About Itron
Itron, Inc (NASDAQ: ITRI) is a global technology company that develops innovative solutions to measure, manage and analyze the use of energy and water. Its comprehensive portfolio includes smart meters, data collection devices, communication networks and advanced software applications designed to optimize utility operations and foster sustainable resource management. The company’s offerings enable utilities and cities to accurately monitor consumption patterns, streamline billing processes and improve grid reliability.
Itron’s product lineup spans a range of hardware and software solutions, from residential and commercial smart meters to meter data management systems (MDMS), networked communication platforms and analytics tools.
Read More
- Five stocks we like better than Itron
- The day the gold market broke
- ~$1.5T SpaceX IPO: Pre-IPO Opportunity
- Forget AI, This Will Be the Next Big Tech Breakthrough
- Gold’s getting scarce.
- End of America Update
Receive News & Ratings for Itron Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Itron and related companies with MarketBeat.com's FREE daily email newsletter.
